CFMS - コンフォ―MIS (ConforMIS Inc.) コンフォ―MIS

 CFMSのチャート


 CFMSの企業情報

symbol CFMS
会社名 Conformis Inc (コンフォ―MIS)
分野(sector) Health Care   ヘルスケア
産業(industry) Industrial Specialties  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 コンフォーMIS(ConforMIS Inc.)は医療技術会社である。同社はiFit Image-to-Implant技術プラットフォームを使用して、各患者の解剖学的構造に適合するように各サイズおよび形状の関節置換インプラントを開発・製造・販売する。同社のiFitテクノロジープラットフォームは、多様なジョイントに適用される。それは、患者の膝の自然な形状を復元するように設計されたカスタマイズされた膝インプラントのラインを提供する。同社のiFit技術プラットフォームは、カスタマイズされたインプラントを設計し、患者のコンピューター断層撮影スキャンに基づいてiJigと呼ばれる関連する使い捨ての患者固有の機器を設計し、患者用にカスタマイズされた手術計画(iView)を作成するために使用されるiFit Design、iJigを製造するために使用される3次元印刷技術であるiFit Printing、及びiFitジャストインタイムの製造・配送機能を提供する。   コンフォ―MISは米国の医療機器メ―カ―。独自の技術「iFit Image-to-Implant」プラットフォ―ムで、患者の骨格に合わせた形状の人口膝関節インプラントの開発、製造、販売を手掛ける。主要製品には「iTotal CR」、「iUni」、「iDuo」、「iPoly」などがある。本社はマサチュ―セッツ州ベッドフォ―ド。  
本社所在地 600 Technology Park Drive Billerica MA 01821 USA
代表者氏名 Kenneth Fallon ケネス・ファロン
代表者役職名 Independent Chairman of the Board
電話番号 +1 781-345-9001
設立年月日 38047
市場名 NASDAQ National Market System
ipoyear 2015年
従業員数 350人
url www.conformis.com
nasdaq_url https://www.nasdaq.com/symbol/cfms
adr_tso
EBITDA EBITDA(百万ドル) -43.70400
終値(lastsale) 0.93
時価総額(marketcap) 58750463.13
時価総額 時価総額(百万ドル) 57.73339
売上高 売上高(百万ドル) 77.93200
企業価値(EV) 企業価値(EV)(百万ドル) 40.87339
当期純利益 当期純利益(百万ドル) -50.36900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ConforMIS Inc revenues decreased less than 1% to $38.8M. Net loss decreased 11% to $26.1M. Revenues reflect United States segment increase of 7% to $16.4M also reflect Germany (Country) segment decrease of 10% to $2.2M Rest of World segment decrease of 8% to $366K. Lower net loss reflects General and administrative - Other decrease of 19% to $11.1M (expense).

 CFMSのテクニカル分析


 CFMSのニュース

   Conformis (NASDAQ:CFMS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS  2021/03/04 14:52:28 Transcript Daily
Conformis (NASDAQ:CFMS) released its quarterly earnings results on Wednesday. The medical instruments supplier reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.02, Fidelity Earnings reports. Conformis had a negative net margin of 32.11% and a negative return on equity of 174.01%. CFMS opened at $1.01 on Thursday. The […]
   ConforMIS Spikes On Australian Approval News  2021/03/02 15:42:52 Benzinga
Shares of ConforMIS (NASDAQ: CFMS ) traded up as high as 37% in Tuesday's pre-market trading session. The company released a press release stating that the Therapeutic Goods Administration, part of the Australian Department of Health, cleared ConforMIS's total knee replacement system. Why It's Important: The global knee-replacement market is valued at around $9 billion. Now that the system is … Full story available on Benzinga.com
   CFMS Stock: Why Under-the-Radar Conformis Is on the Move  2021/03/02 14:13:03 InvestorPlace
CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.
   Knee Replacement Market - Zimmer Biomet, Stryker Corporation, Smith & Nephew Plc, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Medacta International, MicroPort Scientific Corporation, ConforMIS, Inc.  2021/03/01 13:58:42 OpenPR
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are
   Conformis, Inc. Announces Proposed Public Offering of Common Stock  2021/02/11 16:01:00 Benzinga
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that it intends to offer shares of its common stock in an …
   Conformis (NASDAQ:CFMS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS  2021/03/04 14:52:28 Transcript Daily
Conformis (NASDAQ:CFMS) released its quarterly earnings results on Wednesday. The medical instruments supplier reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.02, Fidelity Earnings reports. Conformis had a negative net margin of 32.11% and a negative return on equity of 174.01%. CFMS opened at $1.01 on Thursday. The […]
   ConforMIS Spikes On Australian Approval News  2021/03/02 15:42:52 Benzinga
Shares of ConforMIS (NASDAQ: CFMS ) traded up as high as 37% in Tuesday's pre-market trading session. The company released a press release stating that the Therapeutic Goods Administration, part of the Australian Department of Health, cleared ConforMIS's total knee replacement system. Why It's Important: The global knee-replacement market is valued at around $9 billion. Now that the system is … Full story available on Benzinga.com
   CFMS Stock: Why Under-the-Radar Conformis Is on the Move  2021/03/02 14:13:03 InvestorPlace
CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.
   Knee Replacement Market - Zimmer Biomet, Stryker Corporation, Smith & Nephew Plc, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Medacta International, MicroPort Scientific Corporation, ConforMIS, Inc.  2021/03/01 13:58:42 OpenPR
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are
   Conformis, Inc. Announces Proposed Public Offering of Common Stock  2021/02/11 16:01:00 Benzinga
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that it intends to offer shares of its common stock in an …
   Conformis (NASDAQ:CFMS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS  2021/03/04 14:52:28 Transcript Daily
Conformis (NASDAQ:CFMS) released its quarterly earnings results on Wednesday. The medical instruments supplier reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.02, Fidelity Earnings reports. Conformis had a negative net margin of 32.11% and a negative return on equity of 174.01%. CFMS opened at $1.01 on Thursday. The […]
   ConforMIS Spikes On Australian Approval News  2021/03/02 15:42:52 Benzinga
Shares of ConforMIS (NASDAQ: CFMS ) traded up as high as 37% in Tuesday's pre-market trading session. The company released a press release stating that the Therapeutic Goods Administration, part of the Australian Department of Health, cleared ConforMIS's total knee replacement system. Why It's Important: The global knee-replacement market is valued at around $9 billion. Now that the system is … Full story available on Benzinga.com
   CFMS Stock: Why Under-the-Radar Conformis Is on the Move  2021/03/02 14:13:03 InvestorPlace
CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.
   Knee Replacement Market - Zimmer Biomet, Stryker Corporation, Smith & Nephew Plc, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Medacta International, MicroPort Scientific Corporation, ConforMIS, Inc.  2021/03/01 13:58:42 OpenPR
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are
   Conformis, Inc. Announces Proposed Public Offering of Common Stock  2021/02/11 16:01:00 Benzinga
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that it intends to offer shares of its common stock in an …

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 コンフォ―MIS CFMS ConforMIS Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)